for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Rubius Therapeutics Inc

RUBY.O

Latest Trade

8.09USD

Change

0.02(+0.25%)

Volume

74,966

Today's Range

7.94

 - 

8.24

52 Week Range

6.96

 - 

20.04

As of on the NASDAQ ∙ Minimum 15 minute delay

Officers & DirectorsAs of

NameAgePositionAppointed
David R. Epstein
Chairman of the Board
56Chairman of the Board--
Pablo J. Cagnoni
Chief Executive Officer, Director
56Chief Executive Officer, Director2018
Noubar B. Afeyan
Co-Founder, Director
56Co-Founder, Director--
Avak Kahvejian
Co-Founder & Chief Innovation Officer
--Co-Founder & Chief Innovation Officer--
Andrew M. Oh
Chief Financial Officer
47Chief Financial Officer2017
Nathan J. Dowden
Chief Operating Officer
--Chief Operating Officer2019
Kris Elverum
Senior Vice President - Business Development and Strategy
--Senior Vice President - Business Development and Strategy2019
Laurence Turka
Chief Scientific Officer
--Chief Scientific Officer2020
Joanne M. Protano
Vice President - Finance
--Vice President - Finance--
Christina M Coughlin
Chief Medical Officer
--Chief Medical Officer2020
Greg Whitehead
Senior Vice President and Chief Quality Officer
--Senior Vice President and Chief Quality Officer2019
Maiken Keson-Brookes
Chief Legal Officer, Corporate Secretary
--Chief Legal Officer, Corporate Secretary2019
Francis M. Cuss
Independent Director
63Independent Director2018
Natalie C. Holles
Independent Director
46Independent Director2019
Anne Prener
Independent Director
--Independent Director2019
Michael Rosenblatt
Independent Director
72Independent Director2014
Catherine A. Sohn
Independent Director
65Independent Director2018
Jonathan Richard Symonds
Independent Director
60Independent Director2018

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up